Correlation Between Ocean Biomedical and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ocean Biomedical and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ocean Biomedical and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ocean Biomedical and Larimar Therapeutics, you can compare the effects of market volatilities on Ocean Biomedical and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ocean Biomedical with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ocean Biomedical and Larimar Therapeutics.
Diversification Opportunities for Ocean Biomedical and Larimar Therapeutics
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Ocean and Larimar is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Ocean Biomedical and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Ocean Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ocean Biomedical are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Ocean Biomedical i.e., Ocean Biomedical and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Ocean Biomedical and Larimar Therapeutics
Given the investment horizon of 90 days Ocean Biomedical is expected to under-perform the Larimar Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Ocean Biomedical is 1.77 times less risky than Larimar Therapeutics. The stock trades about -0.3 of its potential returns per unit of risk. The Larimar Therapeutics is currently generating about -0.14 of returns per unit of risk over similar time horizon. If you would invest 801.00 in Larimar Therapeutics on August 27, 2024 and sell it today you would lose (168.00) from holding Larimar Therapeutics or give up 20.97% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ocean Biomedical vs. Larimar Therapeutics
Performance |
| Timeline |
| Ocean Biomedical |
| Larimar Therapeutics |
Ocean Biomedical and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ocean Biomedical and Larimar Therapeutics
The main advantage of trading using opposite Ocean Biomedical and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ocean Biomedical position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.| Ocean Biomedical vs. Enveric Biosciences | Ocean Biomedical vs. Hepion Pharmaceuticals | Ocean Biomedical vs. Elevation Oncology | Ocean Biomedical vs. Zura Bio Limited |
| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |